Found 6 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
C-C chemokine receptor type 5
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radiolig... |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 4
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against C-C chemokine receptor type 4 |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 1
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Compound was evaluated for inhibitory activity against C-C chemokine receptor type 1 |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 3
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against C-C chemokine receptor type 3 |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |
C-X-C chemokine receptor type 4
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against C-X-C chemokine receptor type 4 |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |
C-C chemokine receptor type 2
(Homo sapiens (Human)) | BDBM50106949
(Allyl-{1-[4-(2-ethyl-benzoimidazol-1-yl)-3-phenyl-...)Show SMILES CCc1nc2ccccc2n1CC(CCN1CCC(CC1)N(CC=C)C(=O)OCc1ccc(cc1)[N+]([O-])=O)c1ccccc1 Show InChI InChI=1S/C35H41N5O4/c1-3-21-38(35(41)44-26-27-14-16-31(17-15-27)40(42)43)30-19-23-37(24-20-30)22-18-29(28-10-6-5-7-11-28)25-39-33-13-9-8-12-32(33)36-34(39)4-2/h3,5-17,29-30H,1,4,18-26H2,2H3 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description Compound was evaluated for its inhibitory activity against C-C chemokine receptor type 2 |
Bioorg Med Chem Lett 11: 3103-6 (2001)
BindingDB Entry DOI: 10.7270/Q2FT8K91 |
More data for this Ligand-Target Pair | |